BIIB vs JNJ: Side-by-Side Comparison
Compare Biogen Inc (BIIB) and Johnson & Johnson (JNJ) side by side: market cap USD 31.91B vs USD 633.19B, P/E 23.2 vs 30.4. Financials, growth and model signals on Bullrun.
| Metric | BIIB | JNJ |
|---|---|---|
| Company | Biogen Inc | Johnson & Johnson |
| Country / Exchange | United States · NASDAQ | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 31.91B | USD 633.19B |
| P/E ratio | 23.2 | 30.4 |
| Dividend yield | — | 1.99% |
| Valuation model | 5.7% undervalued | 3.0% undervalued |
| Revenue (FY2025) | USD 9.89B | USD 94.19B |
| Revenue growth YoY | +2.2% | +6.0% |
| Net income | USD 1.29B | USD 26.80B |
| Gross margin | 75.7% | 67.9% |
| Diluted EPS | 8.79 | 11.03 |